USE OF BLOOD COMPONENTS IN EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)-TREATED PATIENTS WITH COVID-19
Aim: Studies about the use of blood in patients in extracorporeal membrane oxygenation (ECMO) because of COVID-19 are scarce. This study aims to evaluate retrospectively the use of blood components by patients in ECMO diagnosed with COVID-19 from March 2020 to July 2022, considering the consumption...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137923015821 |